临床路径管理在结节性甲状腺肿住院患者中的应用

Application of a clinical pathway for nodular goiter patients

目的:探讨临床路径管理在控制结节性甲状腺肿患者住院费用及住院天数等方面的效果及应用价值。方法:采用回顾性队列研究的方式比较临床路径实施前、后结节性甲状腺肿住院患者的相关情况,主要评价指标包括,住院费用、住院天数、医疗质量等。结果:两组患者的临床与病理诊断符合率之间差异无统计学意义(P>0.05),而路径组患者的住院并发症发生率明显低于对照组(P<0.05)。住院费用方面,路径组的平均住院总费用、药费、治疗费、材料费均少于对照组;住院天数方面,平均住院总天数和术后住院天数均少于对照组,差异有统计学意义(P<0.05)。结论:结节性甲状腺肿临床路径管理可以缩短平均住院日、降低住院费用、提高诊疗质量,值得进一步推广。

Objective：To evaluate the effects of clinical path management in the treatment of nodular goiter. Methods：A retrospective cohort study was applied to compare the status between traditional group and the clinical pathway group. Results： In two groups there were no statistically significant difference （ P 〉 0.05 ） in clinical and pathological diagnosis rate. In - hospital complications path group patients were significantly lower than the control group（ P 〈 0.05 ）. The hospital charges, the path group average total cost of hospitalization, drug, treatment costs, material costs were lower than the control group. Hospitalization days, average hospitalization days and the postoperative hospital stay were less than that of the control group, the difference was statistically significant （ P 〈 0.05 ）. Conclusion ： Clinical pathway management of nodular goiter patients can shorten the hospitalization costs, improving the quality of diagnosis and treatment,the average hospitalization days.